基本信息
浏览量:199
职业迁徙
个人简介
Dr. Aaronson is an internationally recognized cancer biologist, who in early studies established the transformation-competent but replication defective nature of mammalian sarcoma viruses and molecularly cloned many of their oncogenes. He and colleagues implicated retroviral-related oncogenes in human cancer through investigations including the initial detection of their expression in human tumors and critical contributions to the demonstration of their involvement in human cancer. His investigations of the v-sis oncogene established the first normal function of an oncogene and the role of oncogenes in growth factor signaling. His discovery of erbB2 as a v-erbB-related gene amplified in a human breast carcinoma and demonstration of its transforming properties paved the way for targeted therapies directed against its product.
He isolated KGF (FGF7), a growth factor with novel epithelial cell specificity and demonstrated its involvement in wound repair. Its successful phase III clinical trial by Amgen for treatment of mucositis, recently led the FDA to approve Kepivance (KGF) for treatment of this debilitating side effect of many cancer therapies. Thus, Dr. Aaronson's pioneering discoveries have directly led to new therapies for cancer patients.
His development and application of stable expression cDNA cloning technology resulted in his identification of new human oncogenes, growth factor receptors, and other genes, which induce transformation or drug resistance. He and colleagues identified the protooncogene product, MET, as the receptor for HGF/Scatter Factor and LRP5/6 as the receptor for a novel Wnt antagonist, Dkk1. This latter discovery paved the way for his recent demonstration with colleagues of a Wnt autocrine transforming mechanism in human malignancies.
Dr. Aaronson received his M.D. from UCSF in 1966. He joined the National Institutes of Health in 1967 and became Chief of the Laboratory of Cellular and Molecular Biology at the National Cancer Institute in 1977. He joined Mount Sinai in 1994 and is the Jack and Jane B. Aron Professor and Founding Chair, Emeritus of the Department of Oncological Sciences. He is the recipient of numerous awards including the Distinguished Service Medal from the U.S. Public Health Service, the Rhoads Memorial Award from the American Association of Cancer Research, and the Paul Erhlich Prize from Germany. He is the author of over 530 publications, an inventor on more than 50 patents, and serves on numerous editorial boards and scientific advisory committees.
研究兴趣
论文共 258 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
crossref(2023)
François Fay,Line Hansen,Stefanie J. Hectors,Brenda L. Sánchez-Gaytán,Yiming Zhao,Jun Tang,Jazz Munitz,Amr Alaarg,Mounia S. Braza,Anita Gianella,Stuart A. Aaronson,Thomas Reiner,Jørgen Kjems,Robert Langer,Freek J. M. Hoeben,Henk M. Janssen,Claudia Calcagno,Gustav J. Strijkers,Zahi A. Fayad,Carlos Pérez‐Medina,Willem J. M. Mulder
加载更多
作者统计
#Papers: 257
#Citation: 18782
H-Index: 63
G-Index: 132
Sociability: 6
Diversity: 3
Activity: 6
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn